Prediction of OncotypeDX recurrence score using hematoxylin and eosin-stained whole slide images
Abstract The OncotypeDX 21-gene assay guides adjuvant chemotherapy decisions in early-stage, hormone receptor–positive, HER2-negative breast cancer, but cost and turnaround time limit access. This study presents a deep learning-based approach for predicting OncotypeDX recurrence scores directly from...
I tiakina i:
| Ngā kaituhi matua: | , , , , , , , , , , , |
|---|---|
| Hōputu: | Artigo |
| Reo: | Inglês |
| I whakaputaina: |
Nature Portfolio
2026-05-01
|
| Rangatū: | npj Breast Cancer |
| Urunga tuihono: | https://doi.org/10.1038/s41523-026-00937-w |
| Ngā Tūtohu: |
Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!
|